Is advanced renal cell carcinoma becoming a chronic disease?

Lancet. 2010 Aug 21;376(9741):574-5. doi: 10.1016/S0140-6736(10)60816-1.
No abstract available

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Carcinoma, Renal Cell / drug therapy
  • Carcinoma, Renal Cell / pathology
  • Carcinoma, Renal Cell / secondary*
  • Humans
  • Indazoles
  • Intracellular Signaling Peptides and Proteins / metabolism
  • Kidney Neoplasms / pathology*
  • Protein Serine-Threonine Kinases / metabolism
  • Pyrimidines / therapeutic use
  • Receptor Protein-Tyrosine Kinases / antagonists & inhibitors
  • Signal Transduction
  • Sulfonamides / therapeutic use
  • TOR Serine-Threonine Kinases
  • Vascular Endothelial Growth Factor A / metabolism

Substances

  • Antineoplastic Agents
  • Indazoles
  • Intracellular Signaling Peptides and Proteins
  • Pyrimidines
  • Sulfonamides
  • Vascular Endothelial Growth Factor A
  • pazopanib
  • MTOR protein, human
  • Receptor Protein-Tyrosine Kinases
  • Protein Serine-Threonine Kinases
  • TOR Serine-Threonine Kinases